Table of Contents Chapter 1 Overview of Biopharmaceuticals 1.1 Definition of Biopharmaceuticals in This Report 1.2 Commercial Types of Biopharmaceuticals 1.2.1 Monoclonal Antibodies 1.2.2 Interferon 1.2.3 Colony-Stimulating Factor 1.2.4 Erythropoietin 1.2.5 Insulin 1.2.6 Vaccines 1.2.7 Growth Hormones 1.2.8 Other 1.3 Downstream Application of Biopharmaceuticals 1.3.1 Tumor 1.3.2 Diabetes 1.3.3 Cardiovascular 1.3.4 Hemophilia 1.3.5 Other 1.4 Development History of Biopharmaceuticals 1.5 Market Status and Trend of Biopharmaceuticals 2013-2023 1.5.1 Asia Pacific Biopharmaceuticals Market Status and Trend 2013-2023 1.5.2 Regional Biopharmaceuticals Market Status and Trend 2013-2023 Chapter 2 Asia Pacific Market Status and Forecast by Regions 2.1 Market Status of Biopharmaceuticals in Asia Pacific 2013-2017 2.2 Consumption Market of Biopharmaceuticals in Asia Pacific by Regions 2.2.1 Consumption Volume of Biopharmaceuticals in Asia Pacific by Regions 2.2.2 Revenue of Biopharmaceuticals in Asia Pacific by Regions 2.3 Market Analysis of Biopharmaceuticals in Asia Pacific by Regions 2.3.1 Market Analysis of Biopharmaceuticals in China 2013-2017 2.3.2 Market Analysis of Biopharmaceuticals in Japan 2013-2017 2.3.3 Market Analysis of Biopharmaceuticals in Korea 2013-2017 2.3.4 Market Analysis of Biopharmaceuticals in India 2013-2017 2.3.5 Market Analysis of Biopharmaceuticals in Southeast Asia 2013-2017 2.3.6 Market Analysis of Biopharmaceuticals in Australia 2013-2017 2.4 Market Development Forecast of Biopharmaceuticals in Asia Pacific 2018-2023 2.4.1 Market Development Forecast of Biopharmaceuticals in Asia Pacific 2018-2023 2.4.2 Market Development Forecast of Biopharmaceuticals by Regions 2018-2023 Chapter 3 Asia Pacific Market Status and Forecast by Types 3.1 Whole Asia Pacific Market Status by Types 3.1.1 Consumption Volume of Biopharmaceuticals in Asia Pacific by Types 3.1.2 Revenue of Biopharmaceuticals in Asia Pacific by Types 3.2 Asia Pacific Market Status by Types in Major Countries 3.2.1 Market Status by Types in China 3.2.2 Market Status by Types in Japan 3.2.3 Market Status by Types in Korea 3.2.4 Market Status by Types in India 3.2.5 Market Status by Types in Southeast Asia 3.2.6 Market Status by Types in Australia 3.3 Market Forecast of Biopharmaceuticals in Asia Pacific by Types Chapter 4 Asia Pacific Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Biopharmaceuticals in Asia Pacific by Downstream Industry 4.2 Demand Volume of Biopharmaceuticals by Downstream Industry in Major Countries 4.2.1 Demand Volume of Biopharmaceuticals by Downstream Industry in China 4.2.2 Demand Volume of Biopharmaceuticals by Downstream Industry in Japan 4.2.3 Demand Volume of Biopharmaceuticals by Downstream Industry in Korea 4.2.4 Demand Volume of Biopharmaceuticals by Downstream Industry in India 4.2.5 Demand Volume of Biopharmaceuticals by Downstream Industry in Southeast Asia 4.2.6 Demand Volume of Biopharmaceuticals by Downstream Industry in Australia 4.3 Market Forecast of Biopharmaceuticals in Asia Pacific by Downstream Industry Chapter 5 Market Driving Factor Analysis of Biopharmaceuticals 5.1 Asia Pacific Economy Situation and Trend Overview 5.2 Biopharmaceuticals Downstream Industry Situation and Trend Overview Chapter 6 Biopharmaceuticals Market Competition Status by Major Players in Asia Pacific 6.1 Sales Volume of Biopharmaceuticals in Asia Pacific by Major Players 6.2 Revenue of Biopharmaceuticals in Asia Pacific by Major Players 6.3 Basic Information of Biopharmaceuticals by Major Players 6.3.1 Headquarters Location and Established Time of Biopharmaceuticals Major Players 6.3.2 Employees and Revenue Level of Biopharmaceuticals Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Biopharmaceuticals Major Manufacturers Introduction and Market Data 7.1 Roche 7.1.1 Company profile 7.1.2 Representative Biopharmaceuticals Product 7.1.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Roche 7.2 Amgen 7.2.1 Company profile 7.2.2 Representative Biopharmaceuticals Product 7.2.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Amgen 7.3 AbbVie 7.3.1 Company profile 7.3.2 Representative Biopharmaceuticals Product 7.3.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of AbbVie 7.4 Sanofi-Aventis 7.4.1 Company profile 7.4.2 Representative Biopharmaceuticals Product 7.4.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Sanofi-Aventis 7.5 Johnson & Johnson 7.5.1 Company profile 7.5.2 Representative Biopharmaceuticals Product 7.5.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.6 Pfizer 7.6.1 Company profile 7.6.2 Representative Biopharmaceuticals Product 7.6.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Pfizer 7.7 Novo Nordisk 7.7.1 Company profile 7.7.2 Representative Biopharmaceuticals Product 7.7.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novo Nordisk 7.8 Eli Lilly 7.8.1 Company profile 7.8.2 Representative Biopharmaceuticals Product 7.8.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Eli Lilly 7.9 Novartis 7.9.1 Company profile 7.9.2 Representative Biopharmaceuticals Product 7.9.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis 7.10 Merck 7.10.1 Company profile 7.10.2 Representative Biopharmaceuticals Product 7.10.3 Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Merck Chapter 8 Upstream and Downstream Market Analysis of Biopharmaceuticals 8.1 Industry Chain of Biopharmaceuticals 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Biopharmaceuticals 9.1 Cost Structure Analysis of Biopharmaceuticals 9.2 Raw Materials Cost Analysis of Biopharmaceuticals 9.3 Labor Cost Analysis of Biopharmaceuticals 9.4 Manufacturing Expenses Analysis of Biopharmaceuticals Chapter 10 Marketing Status Analysis of Biopharmaceuticals 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Monoclonal Antibodies Table Advantage and Disadvantage of Interferon Table Advantage and Disadvantage of Colony-Stimulating Factor Table Advantage and Disadvantage of Erythropoietin Table Advantage and Disadvantage of Insulin Table Advantage and Disadvantage of Vaccines Table Advantage and Disadvantage of Growth Hormones Table Advantage and Disadvantage of Other Table Consumption Volume of Biopharmaceuticals in Asia Pacific by Regions 2013-2017 Table Revenue of Biopharmaceuticals in Asia Pacific by Regions 2013-2017 Table Consumption Volume of Biopharmaceuticals in Asia Pacific by Regions 2018-2023 Table Revenue of Biopharmaceuticals in Asia Pacific by Regions 2018-2023 Table Consumption Volume of Biopharmaceuticals in Asia Pacific by Types 2013-2017 Table Revenue of Biopharmaceuticals in Asia Pacific by Types 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in China 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in Japan 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in Korea 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in India 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in Southeast Asia 2013-2017 Table Consumption Volume of Biopharmaceuticals by Types in Australia 2013-2017 Table Consumption Volume Forecast of Biopharmaceuticals in Asia Pacific by Types 2018-2023 Table Revenue Forecast of Biopharmaceuticals in Asia Pacific by Types 2018-2023 Table Demand Volume of Biopharmaceuticals in Asia Pacific by Downstream Industry 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in China 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in Japan 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in Korea 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in India 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in Southeast Asia 2013-2017 Table Demand Volume of Biopharmaceuticals by Downstream Industry in Australia 2013-2017 Table Demand Volume Forecast of Biopharmaceuticals in Asia Pacific by Downstream Industry 2018-2023 Table Sales Volume of Biopharmaceuticals in Asia Pacific by Major Players 2013-2017 Table Revenue of Biopharmaceuticals in Asia Pacific by Major Players 2013-2017 Table Headquarters Location and Established Time of Biopharmaceuticals Major Players Table Employees and Revenue Level of Biopharmaceuticals Major Players Table Representative Biopharmaceuticals Product One of Roche Table Representative Biopharmaceuticals Product Two of Roche Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Roche 2013-2017 Table Representative Biopharmaceuticals Product One of Amgen Table Representative Biopharmaceuticals Product Two of Amgen Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Amgen 2013-2017 Table Representative Biopharmaceuticals Product One of AbbVie Table Representative Biopharmaceuticals Product Two of AbbVie Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of AbbVie 2013-2017 Table Representative Biopharmaceuticals Product One of Sanofi-Aventis Table Representative Biopharmaceuticals Product Two of Sanofi-Aventis Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Sanofi-Aventis 2013-2017 Table Representative Biopharmaceuticals Product One of Johnson & Johnson Table Representative Biopharmaceuticals Product Two of Johnson & Johnson Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Biopharmaceuticals Product One of Pfizer Table Representative Biopharmaceuticals Product Two of Pfizer Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Biopharmaceuticals Product One of Novo Nordisk Table Representative Biopharmaceuticals Product Two of Novo Nordisk Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novo Nordisk 2013-2017 Table Representative Biopharmaceuticals Product One of Eli Lilly Table Representative Biopharmaceuticals Product Two of Eli Lilly Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Eli Lilly 2013-2017 Table Representative Biopharmaceuticals Product One of Novartis Table Representative Biopharmaceuticals Product Two of Novartis Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Biopharmaceuticals Product One of Merck Table Representative Biopharmaceuticals Product Two of Merck Table Biopharmaceuticals Sales, Revenue, Price and Gross Margin of Merck 2013-2017